title: Comment on "Therapeutic targeting of Syk in autoimmune diabetes".
authors.forename: Shailendra
authors.initials: S
authors.lastname: Kapoor
mesh_terms: D000631:Aminopyridines; D001327:Autoimmune Diseases / Q000188:drug therapy / Q000201:enzymology / Q000276:immunology; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy / Q000201:enzymology* / Q000276:immunology*; D005921:Glomerulonephritis / Q000188:drug therapy / Q000201:enzymology / Q000276:immunology; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D009025:Morpholines; D010078:Oxazines / Q000627:therapeutic use; D047428:Protein Kinase Inhibitors / Q000494:pharmacology; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D011725:Pyridines / Q000627:therapeutic use; D011743:Pyrimidines; D015427:Reperfusion Injury / Q000188:drug therapy / Q000201:enzymology / Q000276:immunology; D015398:Signal Transduction / Q000187:drug effects / Q000276:immunology; D013154:Spleen / Q000201:enzymology; D000072377:Syk Kinase
chemical_list: D000631:Aminopyridines; D047908:Intracellular Signaling Peptides and Proteins; D009025:Morpholines; C510788:N4-(2,2-dimethyl-3-oxo-4H-pyrid(1,4)oxazin-6-yl)-5-fluoro-N2-(3,4,5-trimethoxyphenyl)-2,4-pyrimidinediamine; D010078:Oxazines; D047428:Protein Kinase Inhibitors; D011725:Pyridines; D011743:Pyrimidines; D011505:Protein-Tyrosine Kinases; C000606896:SYK protein, human; D000072377:Syk Kinase; C523665:fostamatinib